Overview
Alwyn has experience across a wide range of debt capital markets practices. He has acted for banks and a range of issuers across the credit spectrum on the establishment and updates of various debt securities programmes, issuance of investment grade corporate hybrids and high yield bonds.
Work highlights
Among the many matters Alwyn has worked on, he has advised:
- The dealers on the issuance of S$2.5bn Fixed Rate Bonds due 2054 by the Government of Singapore under Government of Singapore's Medium Term Note Programme, where the Government of Singapore is authorised to issue securities for moneys borrowed under the Significant Infrastructure Government Loan Act 2021 of Singapore
- Maybank Singapore as the issuer on the establishment of its US$10bn Global Covered Bond Programme and the concurrent debut issue of €500m 3.439 per cent
- DBS as issuer in its annual update and concurrent offering of triple series of senior medium term notes including (1) US$500m 4.403% notes due 2028, (2) US$1bn floating rate notes due 2028 and (3) US$500m floating rate notes due 2030 under the US$30bn Global Medium Term Note Programme
- DBS Bank as issuer on its update and issuance of €1.25bn 2.5995% covered bonds due 2028 under the US$20bn Global Covered Bond Programme
- The dealers and joint lead managers on the issuance of US$150m 9.50% guaranteed bonds due 2029 exchangeable into ordinary shares of Vingroup Joint Stock Company and the concurrent repurchase of Vinpearl Joint Stock Company's US$425m 3.25% guaranteed exchangeable sustainable bonds due 2026
- The dealer managers on the tender offer by India Airport Infra relating to its outstanding 6.25% senior notes due 2025, and the corresponding redemption offer of non-convertible debentures by Delhi International Airport Limited, of which India Airport Infra was the initial investor – this was the first tender offer and redemption conducted in India in relation to such an orphan bond structure
- The manager on the issuance of A$650m 2.375% senor unsecured convertible notes due 2029 by Telix Pharmaceuticals Limited, a group of international banks on the issuance of US$500m 6.15% notes due 2028 under the US$3.5bn Global Medium Term Note Programme by Shriram Finance
Admissions